Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
About
Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for obesity and cardiometabolic diseases. Their pipeline includes both oral and injectable therapies designed to enhance efficacy, improve patient convenience, and achieve better long-term outcomes, with a particular emphasis on patient-friendly options like once-weekly dosing. The company leverages advancements in gut-brain biology to create novel medicines addressing significant unmet medical needs globally.
Tags
Total Employees
74
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Verdiva Bio do?
Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for obesity and cardiometabolic diseases. Their pipeline includes both oral and injectable therapies designed to enhance efficacy, improve patient convenience, and achieve better long-term outcomes, with a particular emphasis on patient-friendly options like once-weekly dosing. The company leverages advancements in gut-brain biology to create novel medicines addressing significant unmet medical…
How much funding has Verdiva Bio raised?
Verdiva Bio has raised a total of $170M in funding. The most recent round on record is Series B.
Where is Verdiva Bio headquartered?
Verdiva Bio is headquartered in San Diego, United States.
When was Verdiva Bio founded?
Verdiva Bio was founded in 2021.
What industry does Verdiva Bio operate in?
Verdiva Bio operates in Biotechnology, Pharmaceuticals, HealthTech, Medical Devices, Biotech, Drug Discovery.
How many employees does Verdiva Bio have?
Verdiva Bio has approximately 74 people on record.